Suppr超能文献

相似文献

1
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.
ACS Med Chem Lett. 2020 Dec 18;12(1):129-135. doi: 10.1021/acsmedchemlett.0c00573. eCollection 2021 Jan 14.
2
Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
Recent Pat Inflamm Allergy Drug Discov. 2010 Jan;4(1):1-15. doi: 10.2174/187221310789895603.
3
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.
ACS Med Chem Lett. 2020 Sep 24;11(11):2244-2252. doi: 10.1021/acsmedchemlett.0c00387. eCollection 2020 Nov 12.
5
Development of PI3Kγ selective inhibitors: the strategies and application.
Acta Pharmacol Sin. 2024 Feb;45(2):238-247. doi: 10.1038/s41401-023-01166-8. Epub 2023 Oct 6.
7
Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
Thromb Haemost. 2008 Feb;99(2):279-85. doi: 10.1160/TH07-10-0632.
9
Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
J Med Chem. 2019 May 23;62(10):4783-4814. doi: 10.1021/acs.jmedchem.8b01298. Epub 2018 Dec 24.

引用本文的文献

1
Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids.
Biochem Biophys Rep. 2024 Nov 18;40:101861. doi: 10.1016/j.bbrep.2024.101861. eCollection 2024 Dec.
2
Development of PI3Kγ selective inhibitors: the strategies and application.
Acta Pharmacol Sin. 2024 Feb;45(2):238-247. doi: 10.1038/s41401-023-01166-8. Epub 2023 Oct 6.
3
Macrophage polarization in diabetic wound healing.
Burns Trauma. 2022 Dec 29;10:tkac051. doi: 10.1093/burnst/tkac051. eCollection 2022.
4
Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases.
Cell Stress. 2021 Mar 8;5(4):40-51. doi: 10.15698/cst2021.04.246.

本文引用的文献

1
Acetylene Group, Friend or Foe in Medicinal Chemistry.
J Med Chem. 2020 Jun 11;63(11):5625-5663. doi: 10.1021/acs.jmedchem.9b01617. Epub 2020 Feb 19.
3
Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts.
J Med Chem. 2018 Mar 8;61(5):1767-1773. doi: 10.1021/acs.jmedchem.7b00762. Epub 2017 Aug 18.
4
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate.
ACS Med Chem Lett. 2016 Jul 22;7(9):862-7. doi: 10.1021/acsmedchemlett.6b00238. eCollection 2016 Sep 8.
5
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ.
J Med Chem. 2015 Jul 23;58(14):5684-8. doi: 10.1021/acs.jmedchem.5b00498. Epub 2015 Jul 6.
6
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
J Med Chem. 2015 Jan 8;58(1):517-21. doi: 10.1021/jm500362j. Epub 2014 May 2.
7
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.
Open Rheumatol J. 2012;6:245-58. doi: 10.2174/1874312901206010245. Epub 2012 Sep 7.
9
Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.
Future Med Chem. 2011 Dec;3(16):2063-77. doi: 10.4155/fmc.11.149.
10
The emerging mechanisms of isoform-specific PI3K signalling.
Nat Rev Mol Cell Biol. 2010 May;11(5):329-41. doi: 10.1038/nrm2882. Epub 2010 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验